Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and Aging
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
A prospective analysis of risk factors for Alzheimer's disease was a major objective of the Canadian Study of Health and Aging, a nationwide, population-based study. Of 6,434 eligible subjects aged 65 years or older in 1991, 4,615 were alive in 1996 and participated in the follow-up study. All participants were cognitively normal in 1991 when they completed a risk factor questionnaire. Their cognitive status was reassessed 5 years later by using a similar two-phase procedure, including a screening interview, followed by a clinical examination when indicated. The analysis included 194 Alzheimer's disease cases and 3,894 cognitively normal controls. Increasing age, fewer years of education, and the apolipoprotein E epsilon4 allele were significantly associated with increased risk of Alzheimer's disease. Use of nonsteroidal anti-inflammatory drugs, wine consumption, coffee consumption, and regular physical activity were associated with a reduced risk of Alzheimer's disease. No statistically significant association was found for family history of dementia, sex, history of depression, estrogen replacement therapy, head trauma, antiperspirant or antacid use, smoking, high blood pressure, heart disease, or stroke. The protective associations warrant further study. In particular, regular physical activity could be an important component of a preventive strategy against Alzheimer's disease and many other conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In both the Kungsholmen project435 and the Cache County Study,436 a stronger effect of diuretics and particularly potassium-sparing diuretics for the latter436 was found compared with other antihypertensive drugs.”
In the citing paper
“Finally, large cohort studies of men and women have also found an inverse relationship between caffeine consumption and the risk of Parkinson’s disease (90–92) and Alzheimer’s disease (93–95).”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [93]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Measuring Health: A Guide to Rating Scales and Questionnaires
McDowell, I., & Newell, C. (1987) · Cited by 4,207
(1987) · PubMed · Cited by 2,657
Measuring Health: A guide to rating scales and questionnaires
McDowell, I. (2006) · doi:10.1093/acprof:oso/9780195165678.001.0001 · Cited by 2,095
Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
Spitzer, R. L., & Williams, J. (1987) · Cited by 1,823
Physical activity and risk of cognitive impairment and dementia in elderly persons
Laurin, D., Verreault, R., Lindsay, J., MacPherson, K., & Rockwood, K. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.498 · Cited by 1,561 · cited 1×
“More recently, regular physical activity has been found to be protective against cognitive impairment as well as all types of dementia, including Alzheimer’s disease, and an interaction with sex has been reported, suggesting greater protection in women than in men (45).”
BackgroundSelf-citationInfluence of education and occupation on the incidence of Alzheimer's disease
Stern, Y. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370056032 · Cited by 1,434 · cited 1×
“Explanations for the education effect include increased brain reserve (30), selection bias resulting from selective attrition or use of a two-phase diagnostic procedure (27, 31), and confounding by indicators of socioeconomic status linked to education, such as diet, lifestyle, and occupational history (32, 33).”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Cited by
Items 301–400 of 1,000
Mishra, S., Beheshti, I., & Khanna, P. (2021) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2021.3107372 · Cited by 108
“Many researchers have published studies for an understanding of dependency of brain aging factors with different brain disease patterns [11], [13], [14], [19], [21], [29]–[32].”
BackgroundGacar, N., Mutlu, O., Utkan, T., Celikyurt, I. K., Göçmez, S. S., & Ulak, G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.05.017 · Cited by 100
“Several epidemiological studies have indicated an inverse relationship between wine consumption and the incidence of AD (Orgogozo et al., 2003; Lindsay et al., 2002), leading to speculation that resveratrol might contribute to the beneficial effect of wine in AD patients.”
The Proteasome and Oxidative Stress in Alzheimer's Disease
Bonet-Costa, V., Pomatto, L. C.-D., & Davies, K. J. A. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6802 · Cited by 99
“a strong predictor of disease development is age (90).”
Mediterranean Diet in Predementia and Dementia Syndromes
Solfrizzi, V., Frisardi, V., Seripa, D., Logroscino, G., P. Imbimbo, B., D'Onofrio, G., Addante, F., Sancarlo, D., Cascavilla, L., Pilotto, A., et al. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391809 · Cited by 91
“These results were consistent with the findings from other cohort studies [109-112], but not with others [98, 100, 102, 106, 113, 114].”
ResultGeneral risk factors for dementia: A systematic evidence review
Patterson, C., Feightner, J., Garcia, A., & MacKnight, C. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.07.001 · Cited by 97
Gasparini, L., Rusconi, L., Xu, H., Del Soldato, P., & Ongini, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02154.x · Cited by 98
“Several epidemiological studies (McGeer et al. 1996; In’t Veld et al. 2001; Lindsay et al. 2002; Zandi et al. 2002; Etminan et al. 2003) indicate that NSAIDs use reduces the risk of developing AD, slows the progression and decreases the severity of dementia.”
BackgroundBlood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis
Ho, J. K., Moriarty, F., Manly, J. J., Larson, E. B., Evans, D. A., Rajan, K. B., Hudak, E. M., Hassan, L., Liu, E., Sato, N., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17049 · Cited by 106
Work‐related physical activity and the risk of dementia and Alzheimer's disease
Rovio, S., Kåreholt, I., Viitanen, M., Winblad, B., Tuomilehto, J., Soininen, H., Nissinen, A., & Kivipelto, M. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1755 · Cited by 94
“However, previous results from our group (Rovio et al., 2005) and others’ (Yoshitake et al., 1995; Laurin et al., 2001; Lindsay et al., 2002; Richards et al., 2003; Abbott et al., 2004; Podewills et al., 2005) have revealed a significant inverse association between leisure-time physical activity…”
Depressive Symptoms in the Elderly—An Early Symptom of Dementia? A Systematic Review
Wiels, W., Baeken, C., & Engelborghs, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00034 · Cited by 95
The impact of alcohol on Alzheimer's disease: A systematic review
Piazza-Gardner, A. K., Gaffud, T. J. B., & Barry, A. E. (2013) · Aging & Mental Health · doi:10.1080/13607863.2012.742488 · Cited by 94
“Four studies identified light-to-moderate/regular drinking as having the greatest protective effect against AD (Deng et al., 2006; Huang et al., 2002; Lindsay et al., 2002; Ogunniyi et al., 2006), while one study identified moderate-to-high levels of drinking (0.”
BackgroundFischer, K., van Lent, D. M., Wolfsgruber, S., Weinhold, L., Kleineidam, L., Bickel, H., Scherer, M., Eisele, M., van den Bussche, H., Wiese, B., et al. (2018) · Nutrients · doi:10.3390/nu10070852 · Cited by 108
“To our knowledge, two other studies investigated effect modification by APOE ε4 status for the risk of AD or dementia related to coffee, both studies found no significant P values for interaction [73,74].”
ResultLuck, T., Riedel-Heller, S. G., Luppa, M., Wiese, B., Köhler, M., Jessen, F., Bickel, H., Weyerer, S., Pentzek, M., König, H.-H., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291713001918 · Cited by 93
“…factor because, to date, only a few studies have investigated interactions between this factor and APOE ε4 for dementia and AD risk and the findings are inconsistent (e.g. Lindsay et al. 2002; Podewils et al. 2005; Rovio et al. 2005; Kivipelto et al. 2008; Paillard-Borg et al. 2009, 2012).”
BackgroundResultWang, X.-J., Xu, W., Li, J.-Q., Cao, X.-P., Tan, L., & Yu, J.-T. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180856 · Cited by 82
Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease
Wu, L., Xian, X., Xu, G., Tan, Z., Dong, F., Zhang, M., & Zhang, F. (2022) · Mediators of Inflammation · doi:10.1155/2022/7924199 · Cited by 107
The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9063-4 · Cited by 98
Morgan, G. S., Gallacher, J., Bayer, A., Fish, M., Ebrahim, S., & Ben-Shlomo, Y. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-112171 · Cited by 86
Rosenroot (Rhodiola): Potential Applications in Aging-related Diseases
Zhuang, W., Yue, L., Dang, X.-F., Chen, F., Gong, Y., Lin, X., & Luo, Y. (2018) · Aging and Disease · doi:10.14336/ad.2018.0511 · Cited by 97
“of catecholamines and 5-HT in the central nervous system [1, 34].”
BackgroundGeneral anesthetic and the risk of dementia in elderly patients: current insights
Seitz, D. P., Hussain, M., Eckenhoff, R. G., & Berger, M. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s49680 · Cited by 107
Urinary N‐methylpyridinium and trigonelline as candidate dietary biomarkers of coffee consumption
Lang, R., Wahl, A., Stark, T., & Hofmann, T. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000656 · Cited by 90
Traumatic brain injury history is associated with earlier age of onset of Alzheimer disease
LoBue, C., Wadsworth, H., Wilmoth, K., Clem, M., Hart, J., Womack, K. B., Didehbani, N., Lacritz, L. H., Rossetti, H. C., & Cullum, C. M. (2017) · The Clinical Neuropsychologist · doi:10.1080/13854046.2016.1257069 · Cited by 90
“…not all studies are supportive (Dams-O’Connor et al., 2013; Fratiglioni, Ahlbom, Viitanen, & Winblad, 1993; Helmes, Ostbye, & Steenhuis, 2011; Lindsay et al., 2002; Mehta et al., 1999; Xu et al., 2015), the increased likelihood for the later development of AD years or decades following TBI…”
BackgroundSilva, A. C., Lemos, C., Gonçalves, F. Q., Pliássova, A., Machado, N. J., Silva, H. B. L., Canas, P. M., Cunha, R. A., Lopes, J. P., & Agostinho, P. M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.024 · Cited by 95
Alcohol and Dementia – What is the Link? A Systematic Review
Wiegmann, C., Mick, I., Brandl, E. J., Heinz, A., & Gutwinski, S. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s198772 · Cited by 87
Implications of Comorbidity on Costs for Patients With Alzheimer Disease
Kuo, T.-C., Zhao, Y., Weir, S., Kramer, M. S., & Ash, A. S. (2008) · Medical Care · doi:10.1097/mlr.0b013e318178940b · Cited by 88
Rhodiola rosea L. and Alzheimer's Disease: From Farm to Pharmacy
Nabavi, S. F., Braidy, N., Orhan, I. E., Badiee, A., Daglia, M., & Nabavi, S. M. (2016) · Phytotherapy Research · doi:10.1002/ptr.5569 · Cited by 88
Gouthamchandra, K., Sudeep, H. V., Venkatesh, B., & Prasad, K. S. (2017) · Food Science and Human Wellness · doi:10.1016/j.fshw.2017.06.001 · Cited by 89
Caffeine and uric acid mediate glutathione synthesis for neuroprotection
Aoyama, K., Matsumura, N., Watabe, M., Wang, F., Kikuchi-Utsumi, K., & Nakaki, T. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.047 · Cited by 88
Physical Activity and Brain Function in Older Adults at Increased Risk for Alzheimer’s Disease
Smith, J., Nielson, K., Woodard, J., Seidenberg, M., & Rao, S. (2013) · Brain Sciences · doi:10.3390/brainsci3010054 · Cited by 82
“Lindsay and colleagues reported the results of the Canadian Study on Health and Aging, a prospective study of 4615 who were followed for 5 years [53].”
ResultLarsson, S. C., & Orsini, N. (2018) · Nutrients · doi:10.3390/nu10101501 · Cited by 94
“* Results reported for regular versus no regular coffee intake [20]; daily versus no daily coffee intake [21]; or per times/week increase in coffee intake [22].”
BackgroundInfluentialEffect of Exercise on Motor and Nonmotor Symptoms of Parkinson’s Disease
Dashtipour, K., Johnson, E., Kani, C., Kani, K., Hadi, E., Ghamsary, M. G., Pezeshkian, S., & Chen, J. J. (2015) · Parkinson s Disease · doi:10.1155/2015/586378 · Cited by 101
“Since then, other scientists have replicated this finding and clinicians have tried to assess and quantify the effect of exercise on a variety of neurological disorders [6, 7].”
BackgroundMcCarty, M. F. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.01.013 · Cited by 95
“Regular coffee drinkers are at markedly lower risk for Parkinson’s disease [169], and two epidemiological studies suggest that Alzheimer’s disease may also be less common in coffee drinkers [170,171].”
Beneficial and detrimental role of adenosine signaling in diseases and therapy
Liu, H., & Xia, Y. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00350.2015 · Cited by 88
Depression in Alzheimer's Disease. Pathophysiology, Diagnosis, and Treatment
Modrego, P. J. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100153 · Cited by 86
“A population-based cohort of 4615 elderly Cana-dians were followed-up for 5 years and history of depression was not associated with the risk of dementia [8].”
Sattler, C., Erickson, K. I., Toro, P., & Schröder, J. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110548 · Cited by 86
“This result supports the findings of other studies that reported a protective impact of education [1, 14] and SES [43, 44], but is in contrast to other studies which only considered SES to be a protective factor when education was not accounted for as a confounder [45, 46].”
Coffee intake and decreased amyloid pathology in human brain
Kim, J. W., Byun, M. S., Yi, D., Lee, J. H., Jeon, S. Y., Jung, G., Lee, H. N., Sohn, B. K., Lee, J.-Y., Kim, Y. K., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0604-5 · Cited by 86
Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
Allen, G. I., Amoroso, N., Anghel, C., Balagurusamy, V., Bare, C. J., Beaton, D., Bellotti, R., Bennett, D. A., Boehme, K. L., Boutros, P. C., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.006 · Cited by 89
“Another undesirable consequence of the focus on traits measured in common was the inability to incorporate into model development the full spectrum of nongenetic and nonimaging factors that are known to influence cognitive performance [24–27].”
BackgroundCognitive reserve and cortical thickness in preclinical Alzheimer’s disease
Pettigrew, C. A., Soldan, A., Zhu, Y., Wang, M., Brown, T., Miller, M. I., & Albert, M. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9581-y · Cited by 97
“While many studies have observed lower rates of progression to MCI and dementia due to AD among cognitively normal (e.g., Lindsay et al. 2002; Pettigrew et al. 2013; Sattler et al. 2012) or non-demented (e.g., Ngandu et al. 2007; Stern et al. 1994) individuals with higher CR, it is not known if the…”
BackgroundLee, J. (2018) · Journal of Gerontological Nursing · doi:10.3928/00989134-20180814-01 · Cited by 80
Stem-cell-associated structural and functional plasticity in the aging hippocampus.
Jessberger, S., & Gage, F. H. (2008) · Psychology and Aging · doi:10.1037/a0014188 · Cited by 85
“Age is also the major risk factor for neurodegenerative diseases such as Alzheimer’s disease (Lindsay et al., 2002).”
BackgroundPiovesana, A., Rodrigues, E., & Noreña, C. P. Z. (2018) · Phytochemical Analysis · doi:10.1002/pca.2806 · Cited by 85
Wine, alcohol and atherosclerosis: clinical evidences and mechanisms
da Luz, P. L., & Coimbra, S. R. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004000900001 · Cited by 101
“(30) analyzed 6434 subjects aged 65 years or older, who were cognitively normal in 1991; 4615 were alive in 1996 and participated in the follow-up study.”
BackgroundExercise and cognition: Results from the National Long Term Care Survey
Jedrziewski, M. K., Ewbank, D. C., Wang, H., & Trojanowski, J. Q. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.02.004 · Cited by 81
Chen, J., & Chern, Y. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_10 · Cited by 92
Protein Phosphorylation is a Key Mechanism in Alzheimer’s Disease
Oliveira, J., Costa, M., de Almeida, M. S. C., da Cruz e Silva, O. A. B., & Henriques, A. G. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170176 · Cited by 80
“Non-genetic factors, like regular use of nonsteroidal anti-inflammatory drugs, wine and coffee consumption, and regular physical activity have been associated with a lower risk of developing AD; whereas aging and low educational levels, were associated with increased risk of AD incidence [30].”
Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Lemche, E. (2018) · Current Genomics · doi:10.2174/1389202919666171229145156 · Cited by 86
“aspirin, diclofenac), regular coffee and wine consumption [38].”
BackgroundEffects of education on aging-related cortical thinning among cognitively normal individuals
Kim, J. P., Seo, S. W., Shin, H. Y., Ye, B. S., Yang, J.-J., Kim, C., Kang, M., Jeon, S., Kim, H. J., Cho, H., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001884 · Cited by 80
Gómez, L. F., Duperly, J., Lucumí, D., Gámez, R., & Venegas, A. S. (2005) · Gaceta Sanitaria · doi:10.1157/13075953 · Cited by 177
Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD
Qiu, C., Winblad, B., Fastbom, J., & Fratiglioni, L. (2003) · Neurology · doi:10.1212/wnl.61.5.655 · Cited by 84
Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer’s Disease?
Mills, Z., Faull, R. L. M., & Kwakowsky, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043205 · Cited by 96
“(2002) [19] CAN Observational Control HRT− (175) Control HRT+ (47) AD HRT− (189) AD HRT+ (33) HRT use and AD diagnosis NR NR NR Postmenopausal 65+ NR HRT was not a protective or adverse factor for the risk of AD.”
BackgroundAntihypertensive Treatments, Cognitive Decline, and Dementia
Duron, E., & Hanon, O. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091552 · Cited by 81
“Nevertheless, the East Boston cohort study [17] and the Canadian Study of Health and Aging reported no significant associations with dementia [18].”
BackgroundCognitive reserve and its implications for rehabilitation and Alzheimer’s disease
Liberati, G., Raffone, A., & Belardinelli, M. O. (2011) · Cognitive Processing · doi:10.1007/s10339-011-0410-3 · Cited by 89
“…et al. 1993; The Canadian Study of Health and Aging 1994; De Ronchi et al. 1998; Borroni et al. 2008) and incidence (Stern et al. 1994; Fabrigoule et al. 1995; Jacobs et al. 1995; Letenneur et al. 1999; Nielsen et al. 1999; Qiu et al. 2001; Di Carlo et al. 2002; Lindsay et al. 2002) of the disease.”
BackgroundO'Brien, J., Jackson, J. W., Grodstein, F., Blacker, D., & Weuve, J. (2014) · Epidemiologic Reviews · doi:10.1093/epirev/mxt008 · Cited by 79
Griesbach, G. S., Masel, B. E., Helvie, R. E., & Ashley, M. J. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5103 · Cited by 82
Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism
Collier, T. J., Ling, Z. D., Carvey, P. M., Fletcher, A. M., Yurek, D. M., Sladek, J. R., & Kordower, J. H. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.018 · Cited by 86
Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study
Yip, A. G., Green, R. C., Huyck, M., Cupples, L. A., Farrer, L. A., & for the MIRAGE Study Group (2005) · BMC Geriatrics · doi:10.1186/1471-2318-5-2 · Cited by 76
“Background Several cross-sectional [1,2], case-control [3-6], and prospective studies [7-9] have reported an inverse association between nonsteroidal anti-inflammatory drug (NSAID) use and the risk of Alzheimer's disease (AD), whereas others [10-12] have not.”
InfluentialHeikkinen, T., Kalesnykas, G., Rissanen, A., Tapiola, T., Iivonen, S., Wang, J., Chaudhuri, J., Tanila, H., Miettinen, R., & Puoliväli, J. T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.015 · Cited by 83
Military-related risk factors in female veterans and risk of dementia
Yaffe, K., Lwi, S. J., Hoang, T. D., Xia, F., Barnes, D. E., Maguen, S., & Peltz, C. B. (2019) · Neurology · doi:10.1212/wnl.0000000000006778 · Cited by 78
Fukutomi, R., Ohishi, T., Koyama, Y., Pervin, M., Nakamura, Y., & Isemura, M. (2021) · Molecules · doi:10.3390/molecules26020415 · Cited by 82
“A 5-year follow-up study with Canadian participants aged ≥65 years showed that coffee consumption, wine consumption, use of nonsteroidal antiinflammatory drugs, and regular physical activity were associated with a reduced risk of AD [35].”
BackgroundLiu, H., Zhou, Y., & Tang, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6894 · Cited by 82
“…emphasized that caffeine exerts many long‑term beneficial effects, as it may protect against the development of age-related dementia and cognitive decline (29,30), as well as development of Alzheimer's disease and Parkinson's disease (31-34), suggesting that caffeine has neuro-protective effects.”
Caruso, P., Signori, R., & Moretti, R. (2019) · Vascular Health and Risk Management · doi:10.2147/vhrm.s190470 · Cited by 81
Frederiksen, K. S., Verdelho, A., Madureira, S., Bäzner, H., O'Brien, J. T., Fazekas, F., Scheltens, P., Schmidt, R., Wallin, A., Wahlund, L., et al. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4220 · Cited by 82
“Previous studies have shown that physical activity is associated with improved global cognitive function (Lindsay, 2002; Kivipelto et al. 2008; Aarsland et al. 2010).”
BackgroundHanding, E. P., Andel, R., Kadlecova, P., Gatz, M., & Pedersen, N. L. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv038 · Cited by 75
“Previous studies have reported a protective effect for wine (11,12,18), a risk effect for beer (12), or no significant effects for any type (14).”
BackgroundRole of Hemichannels in CNS Inflammation and the Inflammasome Pathway
Kim, Y., Davidson, J. O., Gunn, K. C., Phillips, A. R. J., Green, C. R., & Gunn, A. J. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.12.001 · Cited by 79
The Impact of Physical and Mental Activity on Cognitive Aging
Jak, A. J. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_141 · Cited by 87
“One large-scale population-based study, the Canadian Study of Health and Aging, found reduced risk for AD with exercise, among other lifestyle factors such as wine and coffee consumption (Lindsay et al. 2002) and reported physical activity as a means to reduce risk for cognitive decline and dementia (Laurin et al.”
BackgroundArntzen, K. A., Schirmer, H., Wilsgaard, T., & Mathiesen, E. B. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01371.x · Cited by 88
“significant association between beer and spirit consumption and the risk of Alzheimer s disease (3).”
BackgroundBrain structure and cognitive correlates of body mass index in healthy older adults
Bolzenius, J. D., Laidlaw, D. H., Cabeen, R. P., Conturo, T. E., McMichael, A. R., Lane, E., Heaps, J. M., Salminen, L. E., Baker, L. M., Scott, S. E., et al. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.10.010 · Cited by 83
Sutphin, G. L., Bishop, E., Yanos, M. E., Moller, R. M., & Kaeberlein, M. R. (2012) · Longevity & Healthspan · doi:10.1186/2046-2395-1-9 · Cited by 85
“Chronic, moderate consumption of caffeine has been linked with reduced risk of age-associated neurodegenerative disorders in humans, including dementia [9], Alzheimer’s disease [9-11], and Parkinson’s disease [12-15].”
BackgroundLindsay, J., Sykes, E., McDowell, I., Verreault, R., & Laurin, D. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900202 · Cited by 76
“In CSHA-2, a prospective analysis of risk factors for AD was undertaken (14), based on risk factor data collected in the self-administered version of the questionnaire completed by those without dementia at CSHA-1.”
BackgroundMethodSelf-citationCarman, A. J., Dacks, P. A., Lane, R. F., Shineman, D. W., & Fillit, H. M. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0021-7 · Cited by 85
Current perspectives on pharmacotherapy of Alzheimer's disease
Chopra, K., Misra, S., & Kuhad, A. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.520702 · Cited by 74
“2 Resveratrol Resveratrol, a polyphenolic phytoalexin found in grapes, red wine and berries, has been reported to possess a wide range of biological and pharmacological activities [72].”
BackgroundLifestyle Factors and Dementia in the Oldest-old: The 90+ Study
Paganini-Hill, A., Kawas, C. H., & Corrada, M. M. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000087 · Cited by 71
Akila, P., Asaikumar, L., & Vennila, L. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.067 · Cited by 76
Dementia in China (2015–2050) estimated using the 1% population sampling survey in 2015
Ying-quan, W., Jia, R., Liang, J., Li, J., Qian, S., Li, J., & Xu, Y. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13778 · Cited by 77
Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders
Domenici, M. R., Ferrante, A., Martire, A., Chiodi, V., Pepponi, R., Tebano, M. T., & Popoli, P. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104338 · Cited by 82
Apetz, N., Münch, G. W., Govindaraghavan, S., & Gyengési, E. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917110635 · Cited by 80
“More possible causes and risk factors of AD have been discussed in detail elsewhere and will not be the focus of this review [22, 23].”
BackgroundCholerton, B., Zabetian, C. P., Quinn, J. F., Chung, K. A., Peterson, A. L., Espay, A. J., Revilla, F. J., Devoto, J. L., Watson, G. S., Hu, S., et al. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130189 · Cited by 74
“Higher education is consistently associated with lower levels of dementia [22–24], which may in part account for the lower level of dementia identified in the PANUC cohort.”
Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase‐1
Hascalovici, J. R., Vaya, J., Khatib, S., Holcroft, C. A., Zukor, H., Song, W., Arvanitakis, Z., Bennett, D. A., & Schipper, H. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06213.x · Cited by 72
“In the current study, age, an important risk factor for AD (Tyas et al. 2001; Lindsay et al. 2002), exhibited complex interactions with brain sterol homeostasis.”
BackgroundImpact of paper filtered coffee on oxidative DNA-damage: Results of a clinical trial
Mišík, M., Hoelzl, C., Wagner, K., Cavin, C., Moser, B., Kundi, M., Simic, T., Elbling, L., Kager, N., Ferk, F., et al. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.08.003 · Cited by 77
Turner, M. R., Wotton, C., Talbot, K., & Goldacre, M. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301161 · Cited by 71
Seal, C. J., de Mul, A., Eisenbrand, G., Haverkort, A. J., Franke, K., Lalljie, S. P. D., Mykkänen, H. M., Reimerdes, E. H., Scholz, G., Somoza, V., et al. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508965314 · Cited by 80
“Other benefits discussed include a reduction in the risk of Alzheimer’s disease((235)) and Parkinson’s disease((236)) and, at least among a large group of female nurses tracked over many years, fewer suicides((237)).”
BackgroundGlymphatic fluid transport controls paravascular clearance of AAV vectors from the brain
Murlidharan, G., Crowther, A., Reardon, R. A., Song, J., & Asokan, A. (2016) · JCI Insight · doi:10.1172/jci.insight.88034 · Cited by 72
“Correspondingly, these neurocognitive disorders are more prevalent among the geriatric population (23).”
Risk of Alzheimer’s Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging
Elias, A., Cummins, T. L., Tyrrell, R., Lamb, F., Doré, V., Williams, R. C., Rosenfeld, J. V., Hopwood, M., Villemagne, V. L., & Rowe, C. C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180640 · Cited by 74
“Ageisthestrongestriskfac-torforADandgeneticfactorspositsubstantialrisk [5,7,8].”
Caffeine Consumption and Cognitive Function at Age 70: The Lothian Birth Cohort 1936 Study
Corley, J., Jia, X., Kyle, J. A. M., Gow, A. J., Brett, C. E., Starr, J. M., McNeill, G., & Deary, I. J. (2010) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181c92a9c · Cited by 71
Mak, E., Gabel, S., Mirette, H., Su, L., Williams, G. B., Waldman, A., Wells, K., Ritchie, K., Ritchie, C., & O’Brien, J. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.001 · Cited by 71
“However, its association with AD appears to be less certain compared to FAD mutations and ApoE4 carriage, as several studies have not reported an association between family history of dementia and elevated risk of AD (Lindsay et al., 2002; Tyas et al., 2001).”
Pirolli, N. H., Bentley, W. E., & Jay, S. M. (2021) · Advanced Biology · doi:10.1002/adbi.202000540 · Cited by 77
Role of estrogen in women's Alzheimer's disease risk as modified by APOE
Valencia‐Olvera, A. C., Weng, J. M., Christensen, A., LaDu, M. J., & Pike, C. J. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13209 · Cited by 80
Vila-Luna, S., Cabrera-Isidoro, S., Vila-Luna, L., Juárez, I., Bata-García, J. L., Álvarez-Cervera, F. J., Zapata-Vázquez, R. E., Arankowsky‐Sandoval, G., Heredia-López, F. J., Flores, G., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.053 · Cited by 78
“…consumption of coffee and other caffeinated beverages delays the onset of dementia (Eskelinen and Kivipelto, 2010) and reduces the risk of developing Alzheimer's disease (AD) in elderly people (Maia and de Mendonça, 2002; Lindsay et al., 2002; Eskelinen and Kivipelto, 2010) has accumulated.”
Hypertension and Cognitive Function
Obisesan, T. O. (2009) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.03.002 · Cited by 79
“For example, the East Boston cohort study found no relationship of hypertension to cognitive function in nondemented persons.(36) In concordance with the East Boston study, a Canadian study on health and aging found no association of high blood pressure with cognitive decline or dementia.”
Coffee drinking in middle age is not associated with cognitive performance in old age
Laitala, V. S., Kaprio, J., Koskenvuo, M., Räihä, I., Rinne, J. O., & Silventoinen, K. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27660 · Cited by 70
“The next largest prospective study, conducted in 4088 subjects aged 65 y and followed for 5 y, found that coffee consumption protected against AD (15); the study populations were, however, smaller in other studies, except for one cross-sectional survey of 7063 subjects, in which current coffee drinking enhanced the su…”
BackgroundResultAlcohol, coffee and tea intake and the risk of cognitive deficits: a dose–response meta-analysis
Ran, L. S., Liu, W. H., Fang, Y. Y., Xu, S. B., Li, J., Luo, X., Pan, D. J., Wang, M. H., & Wang, W. (2021) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796020001183 · Cited by 69
Review: Caffeine: Neuroprotective Functions in Cognition and Alzheimer's Disease
Rosso, A., Mossey, J., & Lippa, C. F. (2008) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317508320083 · Cited by 66
“In this study, AD risk was lowered by 30% among coffee drinkers after adjustment for age, sex, and education.(12) The Manitoba Study of Health and Aging (MSHA), a parallel study to the CSHA with some subjects enrolled in both, found no difference in AD incidence during 5 years by coffee consumption after adjustment fo…”
BackgroundResultInfluentialO'Shea, D. M., Fieo, R. A., Hamilton, J. L., Zahodne, L. B., Manly, J. J., & Stern, Y. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4192 · Cited by 63
Decaffeinated coffee prevents scopolamine-induced memory impairment in rats
Jang, Y. J., Kim, J., Shim, J., Kim, C., Jang, J.-H., Lee, K. W., & Lee, H. J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.003 · Cited by 72
Guan, J.-W., Huang, C.-Q., Li, Y.-H., Wan, C.-M., You, C., Wang, Z.-R., Liu, Y.-Y., & Liu, Q.-X. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-111160 · Cited by 66
“Characteristics of the 12 prospective longitudinal studies included in the meta-analysis are shown in Table 2 [10–18] and Table 3 [10–12, 15, 19–21].”
InfluentialZeki Al Hazzouri, A., Vittinghoff, E., Byers, A., Covinsky, K., Blazer, D., Diem, S., Ensrud, K. E., & Yaffe, K. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt139 · Cited by 66
Targeting glucose metabolism for healthy aging
Brewer, R. A., Gibbs, V. K., & Smith, D. L. (2016) · Nutrition and Healthy Aging · doi:10.3233/nha-160007 · Cited by 68
“[3] Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, McDowell I.”
BackgroundProgressive dementia after first-ever stroke: A community-based follow-up study
Srikanth, V. K., Anderson, J. F. I., Donnan, G. A., Saling, M. M., Didus, E., Alpitsis, R., Dewey, H. M., Macdonell, R. A. L., & Thrift, A. G. (2004) · Neurology · doi:10.1212/01.wnl.0000137042.01774.33 · Cited by 67
Tokuchi, R., Hishikawa, N., Kurata, T., Sato, K., Kono, S., Yamashita, T., Deguchi, K., & Abe, K. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.09.012 · Cited by 68
“Similar to an epidemiological study in which low educational attainment was significantly associated with increasing AD risk [22], our present study also confirms that a short educational period confers risk for MCI conversion to AD (Fig.”
ResultCaffeine Intake from Coffee or Tea and Cognitive Disorders: A Meta-Analysis of Observational Studies
Kim, Y.-S., Kwak, S. M., & Myung, S.-K. (2015) · Neuroepidemiology · doi:10.1159/000371710 · Cited by 66
Association of Smoking and Alcohol Drinking with Dementia Risk Among Elderly Men in China
Zhou, S., Zhou, R., Zhong, T., Li, R., Tan, J., & Zhou, H. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141001123356 · Cited by 66
“Some results pointed to a protective effect of alcohol drinking, mostly associated to wine consumption [55, 56].”
BackgroundPotential nutraceutical and food additive properties and risks of coffee: a comprehensive overview
Saeed, M., Naveed, M., Bibi, J., Kamboh, A. A., Phil, L., & Sun, C. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1489368 · Cited by 75
Metadata
- Authors
- Lindsay, J.
- Affiliations
- University of Ottawa (CA)
- Corresponding author
- Lindsay, J.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-09-01
- Volume
- 156
- Issue
- 5
- Pages
- 445-453
- ISSN
- 0002-9262 (ISSN-L)
- OpenAlex
- W2145356433
- Cited by
- 1,261
- References
- 41
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 18 · 2023: 34 · 2022: 47 · 2021: 78 · 2020: 56 · 2019: 56 · 2018: 66 · 2017: 54 · 2016: 73 · 2015: 77 · 2014: 80 · 2013: 63 · 2012: 65
- FWCI
- 24.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- Alzheimer's disease, risk factors, Canadian Study of Health and Aging, APOE ε4, educational attainment, age, nonsteroidal anti-inflammatory drugs, wine consumption, coffee consumption, physical activity, dementia prevention, older adults, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Anti-Inflammatory Agents, Non-Steroidal, Apolipoproteins E, Canada, Educational Status, Female, Humans, Life Style, Male, Prospective Studies, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.